Activity of nasal amphotericin B irrigation against fungal organisms in vitro

American Journal of Rhinology

Volumn 21, Issue 2, 2007, Pages 145-148

  Shirazi, Mobeen A ^a   Stankiewicz, James A ^a   Kammeyer, Pat ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allergic fungal sinusitis; Amphotericin B; Eosinophilic fungal rhinosinusitis; Fungal related chronic rhinosinusitis; Fungicide; In vitro; Nasal irrigation; Topical antifungal therapy

Indexed keywords

AMPHOTERICIN B;

ARTICLE; CULTURE MEDIUM; FUNGUS CULTURE; FUNGUS GROWTH; HUMAN; IN VITRO STUDY; LAVAGE; NOSE CAVITY; NOSE MUCUS; RHINOSINUSITIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHRONIC DISEASE; FUNGI; HUMANS; IRRIGATION; MYCOLOGY; NASAL CAVITY; RHINITIS; SINUSITIS;

EID: 34249795486     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2007.21.2988     Document Type: Article

References (15)

1. Millar JW, Johnston A, and Lamb D. Allergic aspergillosis of the maxillary sinuses. Thorax 36:710, 1981.
2. Katzenstein AA, Sale SR, and Greenberger PA. Allergic aspergillus sinusitis. A newly recognized form of sinusitis. J Allergy Clin Immunol 72:89-93, 1983.
3. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 74:877-884, 1999.
4. Bent JP, and Kuhn FA. Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope 106:1331-1334, 1996.
5. Shin SH, and Ye MK. Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 124:1174-1177, 2004.
6. Ponikau JU, Sherris DA, Weaver A, et al. Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 115:125-131, 2005.
7. Ponikau JU, Sherris DA, Kita H, et al. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 110:862-866, 2002.
8. Rains BM III, and Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 117:1-8, 2003.
9. Kennedy DW, Kuhn FA, Hamilos, DL et al. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: A double blind, placebo-controlled study. Laryngoscope 115:1793-1799, 2005.
10. Stanley P, Macmillian L, Greenstone M, et al. Efficacy of a saccharin for screening to detect abnormal mucociliary clearance. Br J Dis Chest 78:62-65, 1984.
11. Rex JH, and Stevens DA. Systemic antifungal agents. In Mandell, Bennett, & Dolin: Principles and Practice of Infectious Diseases, 6th ed. Philadelphia: Churchill Livingstone, 504, 2005.
12. Cass LM, Efthymiopoulos C, and Bye A. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Clin Pharmacokinet 36(suppl 1):1-11, 1999.
13. Goh YH, and Goode RL. Current status of topical nasal antimicrobial agents. Laryngoscope 110:875-880, 2000.
14. Vidgren P, Vidgren M, Paronen P, et al. Nasal distribution of radioactive drug administered using two dosage forms. Eur J Drug Metab Pharmacokinet 16:426-432, 1991.
15. Hofer E, Neher A, Schrott-Fischer A, et al. Influence of amphotericin B on ciliary beat frequency of nasal mucosa. Laryngoscope 114:1964-1966, 2004.